HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. ASMB | 0.00 |
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:
ASMB) with a Buy and maintains $50 price target.
